WO2008019183A3 - Biopolymer and protein production using type iii secretion systems of gram negative bacteria - Google Patents
Biopolymer and protein production using type iii secretion systems of gram negative bacteria Download PDFInfo
- Publication number
- WO2008019183A3 WO2008019183A3 PCT/US2007/069300 US2007069300W WO2008019183A3 WO 2008019183 A3 WO2008019183 A3 WO 2008019183A3 US 2007069300 W US2007069300 W US 2007069300W WO 2008019183 A3 WO2008019183 A3 WO 2008019183A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- type iii
- negative bacteria
- gram negative
- biopolymer
- iii secretion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
- C07K14/43586—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from silkworms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Insects & Arthropods (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Proteins, polynucleotide, expression cassette, vector and bacterium compositions for obtaining proteins of interest by expression of same in gram negative bacteria having a Type III secretion system are provided. Uses of the proteins so obtained in the manufacture of isolated proteins, silks, fibers threats, and pharmaceutical compositions are also provided.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80175806P | 2006-05-18 | 2006-05-18 | |
| US60/801,758 | 2006-05-18 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2008019183A2 WO2008019183A2 (en) | 2008-02-14 |
| WO2008019183A3 true WO2008019183A3 (en) | 2008-12-04 |
Family
ID=39033539
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2007/069300 Ceased WO2008019183A2 (en) | 2006-05-18 | 2007-05-18 | Biopolymer and protein production using type iii secretion systems of gram negative bacteria |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2008019183A2 (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015078840A1 (en) * | 2013-11-26 | 2015-06-04 | Boehringer Ingelheim International Gmbh | Full and partial protein secretion and cell surface display using type iii secretion system |
| KR102648293B1 (en) * | 2014-05-21 | 2024-03-15 | 우니페르시테트 바젤 | Bacteria-based protein delivery |
| HRP20211191T1 (en) | 2015-11-19 | 2021-10-29 | Universität Basel | Virulence attenuated bacteria for treatment of malignant solid tumors |
| WO2017087827A1 (en) * | 2015-11-19 | 2017-05-26 | President And Fellows Of Harvard College | Method of making recombinant silk andsilk-amyloid hybrid proteins using bacteria |
| US12351805B2 (en) | 2015-11-19 | 2025-07-08 | Northeastern University | Method of making recombinant silk and silk-amyloid hybrid proteins using bacteria |
| PT3377634T (en) * | 2015-11-19 | 2020-11-16 | Univ Basel | Bacteria-based protein delivery |
| CA3046852A1 (en) | 2016-12-20 | 2018-06-28 | Universitat Basel | Virulence attenuated bacteria based protein delivery |
| WO2018132821A2 (en) * | 2017-01-13 | 2018-07-19 | Bolt Threads, Inc. | Elastomeric proteins |
| WO2019090267A1 (en) * | 2017-11-03 | 2019-05-09 | The Regents Of The University Of California | Methods and compositions useful for inhibiting growth of certain bacteria |
| US11178934B2 (en) | 2018-07-18 | 2021-11-23 | Bolt Threads Inc. | Resilin material footwear and fabrication methods |
| EP3932937A1 (en) * | 2020-07-03 | 2022-01-05 | Universitätsklinikum Hamburg-Eppendorf | Novel protein translocation domain |
| WO2023076924A1 (en) | 2021-10-26 | 2023-05-04 | Rensselaer Polytechnic Institute | Systems and methods for increased production of recombinant biopolymers via genome engineering and downregulation of basal expression |
-
2007
- 2007-05-18 WO PCT/US2007/069300 patent/WO2008019183A2/en not_active Ceased
Non-Patent Citations (3)
| Title |
|---|
| DARWIN ET AL.: "The putative invasion proteiin chaperone SicA acts together with InvF to activate the expression of Salmonella typhimurium virulence genes", MOL. MICROBIOL., vol. 35, no. 4, February 2000 (2000-02-01), pages 949 - 960 * |
| GUZMAN ET AL.: "Direct expression of Bordetella pertussis filamentous hemagglutinin in Escherichia coli and Salmonella typhimurium aroA", INFECT. IMMUN., vol. 59, no. 10, October 1991 (1991-10-01), pages 3787 - 3795 * |
| WINSTANLEY ET AL.: "Type III secretion systems and pathogenicity islands", J. MED. MICROBIOL., vol. 50, no. 2, February 2001 (2001-02-01), pages 116 - 126, XP002580287 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008019183A2 (en) | 2008-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2008019183A3 (en) | Biopolymer and protein production using type iii secretion systems of gram negative bacteria | |
| WO2009114702A3 (en) | Recombinant production of authentic human proteins using human cell expression systems | |
| WO2010069532A8 (en) | Antibodies against human angiopoietin 2 | |
| NZ596658A (en) | Dig-10 insecticidal cry toxins | |
| AU2011206532A8 (en) | Recombinant probiotic bacteria for the prevention and treatment of inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) | |
| WO2008073406A3 (en) | Solvent tolerant microorganisms | |
| WO2011156380A3 (en) | Protein-containing adhesives, and manufacture and use thereof | |
| WO2008021156A3 (en) | Antibodies to il-17a | |
| WO2011121289A3 (en) | Peptides and their use | |
| WO2006082251A3 (en) | Novel hydrophobin fusion products, production and use thereof | |
| WO2008132229A3 (en) | Highly concentrated insulin solutions and compositions | |
| EP3564259A3 (en) | Recognition tags for tgase-mediated conjugation | |
| MY157798A (en) | Ethanol production in non-recombination hosts | |
| EP3162894A3 (en) | Methods for the manufacture of proteolytically processed polypeptides | |
| WO2011146891A3 (en) | High-affinity fully functional soluble single-domain human cd4, antibodies, and related fusion proteins | |
| WO2011100477A3 (en) | Antibodies and processes for preparing the same | |
| WO2008002663A3 (en) | Immunogenic protein constructs | |
| WO2011129462A3 (en) | A YEAST EXTRACT CONTAINING γ-Glu-X OR γ-Glu-X-Gly AND A METHOD FOR PRODUCING THE SAME | |
| WO2009139930A3 (en) | Antibodies and processes for preparing the same | |
| WO2012166665A3 (en) | Broad spectrum antibiotics | |
| WO2009102367A3 (en) | Tight junction protein modulators and uses thereof | |
| WO2008127664A3 (en) | Wheat protein and methods of production | |
| EP2042184A4 (en) | Physiologically active polypeptide, polymer micelle having protein enclosed therein, and process for production of the polymer micelle | |
| WO2010128207A3 (en) | Product and process for its preparation | |
| WO2016179101A3 (en) | Type iii secretion system targeting molecules |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07840188 Country of ref document: EP Kind code of ref document: A2 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 07840188 Country of ref document: EP Kind code of ref document: A2 |